# FDA 483 - Phyllis J. Gee, M.D. - December 17, 2019

Source: https://www.globalkeysolutions.net/records/483/phyllis-j-gee-md/e348746d-a405-44e2-92d2-95a81ac851eb

> FDA 483 for Phyllis J. Gee, M.D. on December 17, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Phyllis J. Gee, M.D.
- Inspection Date: 2019-12-17
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Phyllis J. Gee, M.D. in Frisco, TX, a clinical investigator, revealed significant deviations from the investigational plan. The firm failed to adhere to protocol regarding subject eligibility, proper adverse event collection, treatment compliance, and study procedures. These findings indicate serious deficiencies in the conduct and oversight of clinical trials.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/camille-d-brown/419869d2-1810-40ea-8e8a-687de7013f6a)

Company: https://www.globalkeysolutions.net/companies/phyllis-j-gee-md/a5cc3d39-ee8e-42ac-a316-52f9c2315dea

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9